Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.46 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.46 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.46 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.46 |
| ▸ | P2RY14 | Q15391 | 9/20 | 0.43 |
| ▸ | P2RY2 | P41231 | 6/20 | 0.38 |
| ▸ | P2RY4 | P51582 | 4/20 | 0.38 |
| ▸ | P2RY6 | Q15077 | 5/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32670136 | 0.90 | SLC28A1 (0.48) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL2168188 | 0.89 | SLC28A1 (0.47) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL31439434 | 0.88 | P2RY6 (0.39) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL17745010 | 0.88 | SLC28A1 (0.44) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL15226208 | 0.88 | SLC28A1 (0.46) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL5494602 | 0.88 | SLC28A1 (0.46) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL1044101 | 0.88 | SLC28A1 (0.46) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL29140448 | 0.88 | SLC28A1 (0.42) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL4415322 | 0.87 | SLC28A1 (0.45) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL17627531 | 0.87 | SLC28A1 (0.45) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 773 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025129186-A1 | CLOSTRIDIOIDES DIFFICILE VACCINE AND METHODS OF USE | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2025-06-19 | — | — | WO | claimed |
| EP-4549577-A1 | NOVEL INDUCED CYTOPLASMIC IVT (ICIVT)-LIKE COMPOSITION AND THE RELATED VACCINE MEDICINE DESIGNS THEREOF | Mello Biotech Taiwan Co., Ltd. (TW) | 2025-05-07 | — | — | EP | claimed |
| US-20250115932-A1 | INDUCED CYTOPLASMIC IVT (ICIVT)-LIKE COMPOSITION AND THE RELATED VACCINE MEDICINE DESIGNS THEREOF | MELLO BIOTECH TAIWAN CO., LTD. (TW) | 2025-04-10 | — | — | US | claimed |
| EP-4506456-A1 | NOVEL OXO-RNA COMPOSITIONS AND THE RELATED APPLICATIONS THEREOF | Lin, Shi-Lung (US) | 2025-02-12 | — | — | EP | claimed |
| US-20250019709-A1 | NOVEL OXO-RNA COMPOSITIONS AND THE RELATED APPLICATIONS THEREOF | LIN SHI LUNG (US) | 2025-01-16 | — | — | US | claimed |
| WO-2024173594-A1 | MODIFIED STEM CELL COMPOSITIONS AND METHODS FOR USE | JASPER THERAPEUTICS, INC. (US) | 2024-08-22 | — | — | WO | claimed |
| CN-118019981-A | Methods for characterizing tumors | 蒙彼利埃大学医疗中心 | 2024-05-10 | — | — | CN | claimed |
| WO-2024073678-A2 | PHOSPHOLIPIDS CONTAINING A HETEROCYCLE RING HAVING A TERTIARY AMINE OR AMIDE | OMEGA THERAPEUTICS, INC. (US) | 2024-04-04 | — | — | WO | claimed |
| US-20240093286-A1 | Novel Replicase Cycling Reaction (RCR) and the Related RdRP-Binding Site Designs Thereof | LIN SHI LUNG (US) | 2024-03-21 | — | — | US | claimed |
| WO-2024054020-A1 | COMPOSITION FOR DELIVERING MODIFIED NUCLEIC ACID-CONTAINING MRNA | 아이진 주식회사 | 2024-03-14 | — | — | WO | claimed |
| WO-2023019270-A1 | MODIFIED STEM CELL COMPOSITIONS AND METHODS FOR USE | JASPER THERAPEUTICS, INC. (US) | 2023-02-16 | — | — | WO | claimed |
| WO-2022132926-A1 | TISSUE-SPECIFIC NUCLEIC ACID DELIVERY BY 1,2-DIOLEOYL-3-TRIMETHYLAMMONIUM-PROPANE (DOTAP) LIPID NANOPARTICLES | OMEGA THERAPEUTICS, INC. (US) | 2022-06-23 | — | — | WO | claimed |
| CN-110678548-A | Antiviral therapeutic agent | 埃吉诺维亚公司 | 2020-01-10 | — | — | CN | claimed |
| CN-109477102-A | Nucleic acid product and its method of administration | 菲克特生物科学股份有限公司 | 2019-03-15 | — | — | CN | claimed |
| WO-2017181107-A2 | MODIFIED CPF1 MRNA, MODIFIED GUIDE RNA, AND USES THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2017-10-19 | — | — | WO | claimed |
| CN-107090436-A | RNA preparations for the RNA through modification comprising purifying of reprogrammed cell | 宾夕法尼亚州大学信托人 | 2017-08-25 | — | — | CN | claimed |
| EP-3157573-A2 | ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF | Moderna Therapeutics, Inc. (US) | 2017-04-26 | — | — | EP | claimed |
| EP-3157572-A2 | ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF | Moderna Therapeutics, Inc. (US) | 2017-04-26 | — | — | EP | claimed |
| WO-2015196128-A2 | ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF | MODERNA THERAPEUTICS, INC. (US) | 2015-12-23 | — | — | WO | claimed |
| WO-2015196130-A2 | ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF | MODERNA THERAPEUTICS, INC. (US) | 2015-12-23 | — | — | WO | claimed |